Stemcell Companies Market 2021 By Product (Stem Cell Lines, Instruments, Culture Media, Consumables), By Application (Research, Clinical, Cell and Tissue Banking), By End-User ( Hospitals and Surgical Centers, Pharmaceutical and Biotech Companies, Cell Banks and Tissue Banks, Academic Institutes, Research Laboratories, and CROs) Forecast to 2027

  • Report ID: BMRC 1383 | Number of pages: 200 | Published Date: Jan 2021

    Published | Category: Healthcare | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On Stemcell Companies Market 2021 By Product (Stem Cell Lines, Instruments, Culture Media, Consumables), By Application (Research, Clinical, Cell and Tissue Banking), By End-User ( Hospitals and Surgical Centers, Pharmaceutical and Biotech Companies, Cell Banks and Tissue Banks, Academic Institutes, Research Laboratories, and CROs) Forecast to 2027 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

Stemcell Companies Market is valued at USD 122.60 Million in 2020 and expected to reach USD 258.57 Million by 2027 with the CAGR of 11.25% over the forecast period.

Stemcell Companies Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027- Rising incidences of blood cancer, chronic and genetic diseases, availability of advanced healthcare infrastructure, improved patient outcomes and growing public awareness about the therapeutic potency of stem cell products are some of the major factors driving the growth of the Global Stemcell Companies Market.

Scope of Global Stemcell Companies Market Report-

The top stem cell companies are working hard to make advances in therapies. A stem cell is a cell which used to develop into specialised cell types in the body. In the life sciences sector, stem cell research and regenerative medicine are growing markets. Stem cells are special human cells which are able to develop into many different cell types. Stem cells are the building blocks of life, with special capabilities that are used in both the early and later stages of a human’s life cycle. In the future, stem cell may be used to replace cells and tissues that have been damaged or lost due to disease.

Global Stemcell companies’ market report is segmented on the basis of product, application, end-user and by regional & country level. Based on product, global stemcell companies market is classified into stem cell lines, instruments, culture media and consumables. Based upon stem cell lines, the market is sub-classified into embryonic stem cells (ESCs), hemopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), multipotent adult progenitor stem cells, induced pluripotent stem cells (iPSCs) and       neural stem cells (NSCs). Based upon instruments, global stemcell companies market is sub-classified into bioreactors & incubators, cell sorters and other instruments. Based upon application, global stemcell companies market is classified into research applications, clinical applications and cell and tissue banking applications. Based upon research applications, global stemcell companies market is sub-classified into drug discovery & development and life science research. Based upon Clinical applications, global stemcell companies market is sub-classified into autologous stem cells and allogeneic stem cells. Based upon end-user, global stemcell companies market is classified into hospitals and surgical centers, pharmaceutical and biotech companies, cell banks and tissue banks, academic institutes, research laboratories, and CROs and other end users.

The regions covered in this Stemcell Companies Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Stemcell Companies is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players of Stemcell Companies-

  • Becton
  • Dickinson and Company
  • Bio-Rad Laboratories
  • Miltenyi Biotec
  • Takara Bio Group
  • STEMCELL Technologies
  • Thermo Fisher Scientific
  • Merck Group
  • Anterogen
  • Cellular Dynamics International
  • MEDIPOST
  • Lonza Group
  • Holostem Terapie Avanzate
  • Pluristem Therapeutics
  • Pharmicell
  • Osiris Therapeutics 

 

Stemcell Companies

 

News-

Cesca Therapeutics Acquired Complete Ownership of ThermoGenesis Unit

January 4th, 2019; Cesca Therapeutics completed the acquisition of ThermoGenesis Corp., making it the wholly-owned subsidiary of the Cesca Therapeutics and focused at developing and commercializing automated technologies and medical devices incorporated in the therapies. Also, this acquisition will focus on the manufacturing CAR-T cell therapies for cancer using the automated CAR-TXpress system.

Global Stemcell Companies Market Dynamics–

Rising incidences of blood cancer, chronic and genetic diseases, and availability of advanced healthcare infrastructure, improved patient outcomes and growing public awareness about the therapeutic potency of stem cell products are the major factors driving the growth of the global stemcell companies market. According to Leukemia Research Foundation, more than 175,000 new cases of blood cancer were diagnosed in the United States in 2019. As per National Institutes of Health, in the United States, about 1 in 200,000 people is born with syndrome A per year and An estimated 12,000 people died from syndrome C worldwide in 2015.

In addition, the increasing initiatives for research collaboration, the advancement in cancer research and more patients with cancer are being successfully treated are majorly responsible for the continuous growth of the global stemcell companies market. For example, in 2019, Evotec SE announced the collaboration expansion with Celgene to include a new iPSC. The collaboration followed an innovative approach towards discovering disease-modifying treatments for patients suffering from neurodegenerative diseases by leveraging Evotec's unique human iPSC technology platform, which is one of the largest and most sophisticated platforms in the industry.  However, high costs associated with stem cell manufacturing & banking is may hamper the growth of global stemcell companies market. In spite of that, technological advancements in stem cell-based research may create more opportunities for the further growth of the stemcell companies market.

Global Stemcell Companies Market Regional Analysis–

North America is expected to dominate the global stemcell companies market with highest market share due to the high intensity of stem cell research, rising public-private funding to support the clinical evaluation of stem cells for various applications and rising awareness among the people about advanced treatment for cancers in this region. According to National Cancer Institute’s data report, in the United States, about 414,773 people living with leukemia in 2016. Cancer is one among the leading causes of death and disease within the U.S. In addition, favorable government initiatives and presence of major biotechnology companies are also fostering the market growth in this region.

Asia Pacific stemcell companies market is expected to witness a strong growth majorly due to the high population growth rate, increasing government initiatives regarding awareness in peoples about stem cell banking and  growing prevalence of cardiac diseases, cancers etc. in this region. According to leukemia study report, India has the third highest number of blood cancer patients in the world after the US and China. Blood cancer contributes to 7% of all cancer cases in India. According to report by United Nations, 61% of the global population lives in Asia (4.7 billion). For example, Cord Blood Foundation, provides family cord blood banking means parents pay a private bank to store their baby’s cord blood so that in case of need they will have access to the stem cells for the treatment. In addition, strong product pipelines in cell-based therapies and rising adoption of advanced technologies in emerging countries like Japan, India and China are also supplementing the market growth in this region. For example, HEALIOS K.K. is a Japan-based pharmaceutical company. It is one of the first companies to test the iPS-based treatment in the country.

Key Benefits for Global Stemcell Companies Market Report–

  • Global Stemcell Companies Market report covers in depth historical and forecast analysis.
  • Global Stemcell Companies Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Stemcell Companies Market report helps to identify opportunities in market place.
  • Global Stemcell Companies Market report covers extensive analysis of emerging trends and competitive landscape.

 

Stemcell Companies Market Report Coverage

Report Analysis Details
Years : 2019 Market Size in 2019: US$ 110.2 Million 
Market Historical Analysis: 2015-2019 Forecast Analysis: 2020-2026 
Forecast Period CAGR %: 11.25% Market Size Expected to reach in 2026: US$ 232.3 Billion 
Pages: 200 Tables, Charts & Figures: 174
Top Companies: Becton, Dickinson and Company, Bio-Rad Laboratories, Miltenyi Biotec, Takara Bio Group, STEMCELL Technologies, Thermo Fisher Scientific, Merck Group, Anterogen, Cellular Dynamics International, MEDIPOST, Lonza Group, Holostem Terapie Avanzate, Pluristem Therapeutics, Pharmicell, Osiris Therapeutics and others.
Market Segmentation: Product, End-User, Application
Regional Analysis:  North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

 

Stemcell Companies Market Segmentation:–

By Product:

  • Stem Cell Lines
    • Embryonic Stem Cells (ESCs)
    • Hemopoietic Stem Cells (HSCs)
    • Mesenchymal Stem Cells (MSCs)
    • Multipotent Adult Progenitor Stem Cells
    • Induced Pluripotent Stem Cells (iPSCs)
    • Neural Stem Cells (NSCs)
  • Instruments
    • Bioreactors & Incubators
    • Cell Sorters
    • Other Instruments
  • Culture Media
  • Consumables

By Application:

  • Research Applications
    • Drug Discovery & Development
    • Life Science Research
  • Clinical Applications
    • Autologous Stem Cells
    • Allogeneic Stem Cells
  • Cell and Tissue Banking Applications

By End-User:

  • Hospitals and Surgical Centers
  • Pharmaceutical and Biotech Companies
  • Cell Banks and Tissue Banks
  • Academic Institutes, Research Laboratories, and CROs
  • Other End Users

By Regional & Country Analysis:

  • North America
    • US.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • South America
    • Brazil,
    • Argentina
    • Columbia
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa.


Frequently Asked Questions (FAQ) :
Stemcell Companies Market is valued at USD 122.60 Million in 2020 and expected to reach USD 258.57 Million by 2027 with the CAGR of 11.25% over the forecast period.
Becton, Dickinson and Company, Bio-Rad Laboratories, Miltenyi Biotec, Takara Bio Group, STEMCELL Technologies, Thermo Fisher Scientific, Merck Group, Anterogen, Cellular Dynamics International, MEDIPOST, Lonza Group, Holostem Terapie Avanzate, Pluristem Therapeutics, Pharmicell, Osiris Therapeutics and others. Detail Information
North America is expected to dominate the global stemcell companies market with highest market share due to the high intensity of stem cell research, rising public-private funding to support the clinical evaluation of stem cells for various applications and rising awareness among the people about advanced treatment for cancers in this region.
Rising incidences of blood cancer, chronic and genetic diseases, and availability of advanced healthcare infrastructure, improved patient outcomes and growing public awareness about the therapeutic potency of stem cell products are the major factors driving the growth of the global stemcell companies market.



Interested in this report?

• Stemcell Companies Market Size, Share, Statistics - Industry Size Report 2027

report cover

Request for Table of Content

Stemcell Companies Market 2021 By Product (Stem Cell Lines, Instruments, Culture Media, Consumables), By Application (Research, Clinical, Cell and Tissue Banking), By End-User ( Hospitals and Surgical Centers, Pharmaceutical and Biotech Companies, Cell Banks and Tissue Banks, Academic Institutes, Research Laboratories, and CROs) Forecast to 2027

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.

    Pricing


Looking for Regional Reports?